Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Bosulif by Pfizer for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
Bosulif is under clinical development by Pfizer and currently in Phase II for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic...
Data Insights
Bosulif by Pfizer for Mild Cognitive Impairment: Likelihood of Approval
Bosulif is under clinical development by Pfizer and currently in Phase I for Mild Cognitive Impairment. According to GlobalData, Phase...